Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives

Acta Pharmaceutica

Volumn 58, Issue 3, 2008, Pages 257-274

  Chawla, Garima ^a   Bansal, Arvind K ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Amorphous form; Dissolution rate; Irbesartan; Solid dispersion; Solubility

Indexed keywords

IRBESARTAN;

ARTICLE; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DISSOLUTION; DRUG SOLUBILITY; HYDROPHOBICITY; X RAY POWDER DIFFRACTION;

EID: 53549113334     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-008-0016-1     Document Type: Article

References (25)

1. R. Lobenberg and G. L. Amidon, Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards, Eur. J. Pharm. Biopharm. 50 (2000) 3-12; DOI: 10.1016/S0939-6411(00)00091-6.
2. H. Yan, S. E. Tabibi and S. H. Yalkowsky, Solubilization of two structurally related anticancer drugs: XK-469 and PPA, J. Pharm. Sci. 95 (2006) 97-107; DOI: 10.1002/jps.20500.
3. L. F. Huang and W. Q. Tong, Impact of solid state properties on developability assessment of drug candidates, Adv. Drug Del. Rev. 56 (2004) 321-334; DOI: 10.1016/j.addr.2003.10.007.
4. M. Pudipeddi and A. T. M. Serajuddin, Trends in solubility of polymorphs, J. Pharm. Sci. 94 (2005) 929-939; DOI: 10.1002/jps.20302.
5. D. Q. M. Craig, The mechanisms of drug release from solid dispersions in water-soluble polymers, Int. J. Pharm. 231 (2002) 131-144; DOI: 10.1016/S0378-5173(01)00891-2.
6. G. Chawla and A. K. Bansal, A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug, Eur. J. Pharm. Sci. 32 (2007) 45-57; DOI: 10.1016/j.ejps.2007.05.111.
7. C. J. Mbah, Kinetics of decomposition of irbesartan in aqueous solutions determined by high performance liquid chromatography, Pharmazie 59 (1994) 920-922.
8. E. Garcia, C. Hoff and S. Veesler, Dissolution and phase transition of pharmaceutical compounds, J. Crys. Growth 237-239 (2002) 2233-2239; DOI: 10.1016/S0022-0248(01)02282-5.
9. S. Veesler, L. Lafferrere, E. Garcia and C. Hoff, Phase transitions in supersaturated drug solution, Org. Process Res. Develop. 7 (2003) 983-989; DOI: 10.1021/op034089f.
10. B. Law, S. L. Krill, E. A. Schmitt, J. J. Fort, Y. Qiu, W. Wang and W. R. Porter, Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions, J. Pharm. Sci. 90 (2001) 1015-1025; DOI: 10.1002/jps.1054.
11. V. B. Pokharkar, L. P. Mandpe, M. N. Padamwar, A. A. Ambike, K. R. Mahadik and A. Paradkar, Development, characterization and stabilization of amorphous form of a low Tg drug, Powder Technol. 167 (2006) 20-25; DOI: 10.1016/j.powtec.2006.05.012.
12. W. L. Chiou and S. Riegelman, Pharmaceutical applications of solid dispersion systems, J. Pharm. Sci. 60 (1971) 1281-1302; DOI: 10.1002/jps.2600600902.
13. K. Danjo, T. Nakata and A. Otsuka, Preparation and dissolution behavior of ethenzamide solid dispersions using various sugars as dispersion carriers, Chem. Pharm. Bull. 45 (1997) 1840-1844.
14. A. Forster, J. Hempenstall and T. Rades, Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers, J. Pharm. Pharmacol. 53 (2001) 303-315; DOI: 10.1211/0022357011775532.
15. A. Modi and P. Tayade, Enhancement of dissolution profile by solid dispersion (kneading) technique, AAPS PharmSciTech. 7 (2006) E1-E6; DOI: 10.1208/pt070368.
16. P. R. Nassab, R. Rajko and P. S. Revesz, Physicochemical characterization of meloxicam-mannitol binary systems, J. Pharm. Biomed. Anal. 41 (2006) 1191-1197; DOI: 10.1016/j.jpba.2006.02.055.
17. M. J. Arias, J. R. Moyano and J. M. Gines, Study by DSC and HSM of the oxazepam-PEG 6000 and oxazepam-D-mannitol systems: Application to the preparation of solid dispersions, Thermochim. Acta 321 (1998) 33-41; DOI: 10.1016/S0040-6031(98)00437-7.
18. P. Mura, M. T. Faucci, A. Manderioli, S. Furlanetto and S. Pinzauti, Thermal analysis as a screening technique in preformulation studies on picotinamide solid dosage forms, Drug Dev. Ind. Pharm. 24 (1998) 747-756; DOI: 10.3109/03639049809082722.
19. H. K. Chan, K. L. Au-Yeung and I. Gonda, Development of a mathematical model for the water distribution in freeze-dried solids, Pharmacol. Res. 16 (1999) 660-665; DOI: 10.1023A: 1018812305562.
20. I. Weuts, D. Kempen, A. Decorte, G. Verreck, J. Peeters, M. Brewster and G. van den Mooter, Phase behaviour analysis of solid dispersions of loperamide and two structurally related compounds with the polymers PVP-K30 and PVP-VA64, Eur. J. Pharm. Sci. 22 (2004) 375-385; DOI: 10.1016/j.ejps.2004. 04.002.
21. M. Gordon and J. S. Taylor, Ideal copolymers and the second-order transitions of synthetic rubbers 1: Non-crystalline copolymers, J. Appl. Chem. 2 (1952) 493-498.
22. H. Suzuki and H. Sunada, Comparison of nicotinamide, ethylurea and polyethylene glycol as carriers for nifedipine solid dispersion systems, Chem. Pharm. Bull. 46 (1998) 482-487.
23. A. Forster, T. Rades and J. Hempenstall, Selection of suitable drug and excipient candidates to prepare glass solutions by melt extrusion for immediate release oral formulations, Pharm. Technol. (Europe) (2002) 27-37.
24. P. Sinswat, M. E. Matteucci, K. P. Johnston and R. O. Williams III, Dissolution rates and supersaturation behavior of amorphous repaglinide particles produced by controlled precipitation, J. Biomed. Nanotech. 3 (2007) 18-27; DOI: 10.1166/jbn.2007.001.
25. M. J. Arias, J. M. Gines, J. R. Moyano, J. I. Perez-Martinez and A. M. Rabasco, Influence of the preparation method of solid dispersions on their dissolution rate: Study of triamterene-D-mannitol system, Int. J. Pharm. 123 (1995) 25-31; DOI: 10.1016/0378-5173(95)00026-F.